‘If it’s wrong it’s fine’: Trump teases major announcement on autism

Public Health & Policy - The Trump administration is expected to announce concerns regarding pregnant women's use of acetaminophen (Tylenol) and a potential link to autism [2] - Kenview, the maker of Tylenol, states there is no credible evidence linking acetaminophen to autism [3] - Medical professionals emphasize the importance of evidence-based recommendations and caution against causing confusion among patients [9] - Current medical recommendations from the American College of Obstetricians and Gynecologists still consider Tylenol the safest medication for fever and inflammation during pregnancy [6] - Untreated high fever and inflammation during pregnancy can also increase the risk of autism [7] Autism Treatment - The administration may promote leucovorin as a potential autism treatment [10] - Leucovorin has shown positive results in patients with documented metabolic and receptor deficiencies related to autism spectrum conditions [11] - Experts caution against touting leucovorin as a miracle cure and giving false hope to unqualified patients [11] Medical Community Concerns - The medical community expresses concern that premature announcements without sufficient scientific backing can cause chaos and confusion [9] - Medical professionals emphasize the need for data and studies to support any claims regarding the risk of autism [4][5] - There is concern that discouraging Tylenol use without proper medical guidance could be harmful to pregnant women who need treatment for fever or other symptoms [7]